People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Pharmaceuticals, Healthtech, Other, Biotechnology, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. | — | Pharmaceuticals | Series C | $245.8M | $452.2M | 2023 |
| Supira Medical, Inc. | — | Healthtech | Series D+ | $220.7M | $1.1B | 2020 |
| Bioventrix Inc | — | Other | Series B | $191.3M | $20.8M | 2023 |
| Atea Pharmaceuticals, Inc. | — | Biotechnology | Series D+ | $175.9M | $4.4B | 2018 |
| Chroma Medicine, Inc. | — | Biotechnology | Series D+ | $135.0M | $2.3B | 2023 |
| TP Therapeutics, Inc. | — | Pharmaceuticals | Series C | $126.4M | $2.8B | 2017 |
| Akura Medical, Inc. | — | Healthtech | Series C | $94.8M | $299.4M | 2025 |
| Graviton BioScience Corp | — | Biotechnology | Series B | $93.3M | $213.0M | 2024 |
| Tioga Cardiovascular, Inc. | — | Other Health Care | Series B | $69.8M | $105.6M | 2023 |
| Adona Medical, Inc. | — | Healthtech | Series B | $54.1M | $91.0M | 2020 |
| Atia Vision, Inc. | — | Biotechnology | Series B | $51.0M | $466.4M | 2019 |
| BiVACOR Inc. | — | Other Technology | Series A | $24.0M | $48.3M | 2023 |
| Tiger Biotherapeutics Inc. | — | Other Technology | Series B | $20.0M | $233.9M | 2023 |
| TP Therapeutics, Inc. | — | Pharmaceuticals | Series B | $18.0M | $611.4M | 2015 |
BIHUA CHEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside BIHUA CHEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| AMR SALAHIEH | 5 | 10 |
| Mariam Maghribi | 4 | 6 |
| Yishan Li | 3 | 4 |
| Gautam Kainth | 3 | 3 |
| George Lee | 2 | 6 |
| Casey Gordon | 2 | 4 |
| JAMES DILLON | 2 | 2 |
| JINGRONG JEAN CUI | 2 | 2 |
| Carl Gordon | 1 | 24 |
| Kevin Bitterman | 1 | 15 |
| Gerald Chan | 1 | 13 |
| Michael Kelly | 1 | 11 |
| Kenneth Miller | 1 | 8 |
| Franklin Berger | 1 | 7 |
| Henry Chen | 1 | 7 |
| Michael Taglich | 1 | 7 |
| Ken Miller | 1 | 5 |
| Paul Kelly | 1 | 5 |
| Arthur Bertolero | 1 | 5 |
| Quan Zhou | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.